Pfizer Vaccine Could Get Full FDA Approval Monday

The Food and Drug Administration could approve the Pfizer-BioNTech COVID-19 vaccine by as soon as Monday pushing up its unofficial deadline of around Labor Day.

From the New York Times:

Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.

An F.D.A. spokeswoman declined to comment.

The approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting firmer regulatory backing before implementing mandates.

Recent polling shows some of the current vaccine hesitancy is based on the current ‘Emergency Use Authorization’ status of the Pfizer vaccine. Full FDA approval could encourage more Americans to get their shot.